Abstract: The present invention provides an edible composition for alleviating visual fatigue. The composition comprises in parts by weight 1 to 10 parts of curcuma powder, 1 to 12 parts of whole coffee fruit extract, 1 to 20 parts of phospholipid composite, 1 to 15 parts of DHA, 0.5 to 5 parts of phosphatidylserine, and 0.1 to 5 parts of vitamin C. After one week of trial consumption by the subject, the duration of photopic vision is improved with a significant difference in comparison with that before the trial; after 2 weeks of trial consumption, the overall score of visual fatigue symptoms decreases with a significant difference in comparison with that before the trial; after 8 weeks of trial consumption by the subject, the vision field thereof is remarkably enlarged, indicating the formulation may prevent the occurrence of glaucoma. The coffee extract combined with the remaining ingredients has a synergistic effect.

Abstract: The present invention provides an edible composition for promoting hair growth and delaying hair graying. The composition comprises in parts by weight: 2 to 30 parts of nucleoprotein peptides, 1 to 25 parts of whole coffee fruit extract, 5 to 60 parts of yeast composite powder and 10 to 55 parts of collagen. The edible composition for promoting hair growth and delaying hair graying provided by the present invention can promote hair growth, with a significant change in fine hair after 1 week of consumption and a 2 to 3 times increase in fine hair after 8 weeks of consumption, a significant reduction in the percentage of grey hair after 2 weeks of consumption, and a 10% to 40% reduction in the percentage of grey hair after 8 weeks of consumption. It also has an effect in skin improvement.

Abstract: The invention provides a method of extracting whole coffee fruit, an extract obtained from the method, and method of ameliorating age-related neurodegenerative diseases using said extract. The whole coffee fruit extract may be extracted by water, methanol, ethanol, or acetone and may comprise chlorogenic acid (CA) and procyanidine. The expression levels of p-CREB, BDNF, p-eIF2?, BACE-1, A?, NLRP3, caspase-1, IL-1? and COX-2 which may relate to age-related neurodegenerative diseases can be modulated.